Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Alimentary Pharmacology and Therapeuthics Année : 2022

Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure

(1) , (2) , (3) , (1)
1
2
3

Dates et versions

hal-03566155 , version 1 (11-02-2022)

Identifiants

Citer

Benedicte Caron, Mathurin Fumery, Patrick Netter, Laurent Peyrin-Biroulet. Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure. Alimentary Pharmacology and Therapeuthics, 2022, 55 (4), pp.508-509. ⟨10.1111/apt.16770⟩. ⟨hal-03566155⟩
15 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More